Introduction
Merck is investing over €300 million in a new research center at its global headquarters in Darmstadt, Germany.
Feature
This Advanced Research Center will focus on developing solutions for manufacturing antibodies, mRNA applications, and other biotechnological products.
Covering approximately 18,000 square meters, the Advanced Research Center is designed to promote collaboration across departments in an open, modern work environment.
The facility aims to operate with near-carbon neutrality, using photovoltaic systems, geothermal energy, and air-source heat pumps.
The energy-efficient facades and green roofs will further enhance energy savings and improve the microclimate. The building is striving for gold certification from the German Sustainable Building Council.
The center will consolidate research on key technologies within Merck’s Life Science business sector.
This includes developing raw materials and processes for antibodies, recombinant proteins, and viral vectors, as well as cell culture media, pharmaceutical formulation aids, and digital reference materials.
Additionally, the center will advance analytical chromatography, a technique for separating, identifying, and quantifying chemical substances, and conduct research along the mRNA value chain.
The center is expected to open in early 2027 and will accommodate around 550 employees.
Overall, the Advanced Research Center will support Merck’s customers in Europe and globally by addressing critical medical challenges, fostering scientific progress, and contributing to the development of new medicines.
Specification
Name Research Center
Type New Construction
Year 2027
